Burning Rock Biotech Ltd ADR (BNR) Stock Price, Quote & News

Company Profile

Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast c...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 86 20 3403 7871

Website: www.brbiotech.com

Address:

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, China

MarketBeat May. 13 at 2:08 PM

https://marketbeat.com/a/8652614/ $BNR Brenntag Q1 Earnings Call Highlights

0 · Reply

OfficialStocktwitsUser May. 2 at 1:09 AM

$BNR RSI: 47.04, MACD: -0.6223 Vol: 2.25, MA20: 18.63, MA50: 20.12 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BleedingStockPicker Mar. 16 at 2:00 PM

$BNR when I try to add in Charles Schwab states this order is not allowed for electronic entry. I have to call them. WTF?

1 · Reply

funnymoney90210 Mar. 6 at 3:05 AM

$BNR all chinese stocks getting delisted soon

0 · Reply

OfficialStocktwitsUser Feb. 27 at 9:37 PM

$BNR RSI: 26.28, MACD: -0.9541 Vol: 3.61, MA20: 30.17, MA50: 27.69 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

BillionerOfKing Feb. 22 at 1:50 PM

$BNR Current Stock Price: $29.00

0 · Reply

DeltaWalker Feb. 18 at 10:23 AM

$BNR China clean energy exposure with policy dependency.

0 · Reply

RHoney Feb. 4 at 1:43 PM

$BNR escalating levels of support.

1 · Reply

BillionerOfKing Jan. 28 at 3:13 PM

$BNR Current Stock Price: $35.97

0 · Reply

RHoney Jan. 25 at 12:46 PM

$BNR lots of upside potential , this uptick has a long way to go

0 · Reply

Burning Rock Publishes 2025 Annual Report on Form 20-F

2026-04-02T10:44:32.000Z - 5 weeks ago

Burning Rock Biotech founder and CEO purchases company ADSs

Apr 2, 2026, 6:25 AM EDT - 5 weeks ago

Burning Rock Announces Founder's Purchase of Its ADSs

2026-03-12T11:22:06.000Z - 2 months ago

Burning Rock Biotech reports Q4 EPS (RMB0.16) vs. (RMB0.79) last year

2026-01-05T10:20:07.000Z - 4 months ago

Burning Rock Biotech CEO Yusheng Han purchases $811,721 of ADSs

Dec 22, 2025, 11:04 PM EST - 5 months ago

Burning Rock Announces Results of 2025 Annual General Meeting

Dec 1, 2025, 4:11 AM EST - 5 months ago

Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025

Nov 20, 2025, 1:52 AM EST - 6 months ago

Burning Rock Reports Third Quarter 2025 Financial Results

2025-09-24T09:10:12.000Z - 8 months ago

Burning Rock announces OncoGuide OncoScreen Plus CDx System approval in Japan

AZN

Sep 24, 2025, 2:42 AM EDT - 8 months ago

Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer

Sep 8, 2025, 1:39 AM EDT - 8 months ago

Burning Rock Reports Second Quarter 2025 Financial Results

2025-07-31T14:01:24.000Z - 10 months ago

Burning Rock Biotech Ltd (ADR) trading resumes

2025-07-31T13:55:49.000Z - 10 months ago

Burning Rock Biotech Ltd (ADR) trading halted, volatility trading pause

Jun 6, 2025, 3:31 AM EDT - 1 year ago

Burning Rock Reports First Quarter 2025 Financial Results

2025-03-25T18:44:17.000Z - 1 year ago

Burning Rock Biotech reports Q4 EPS (RMB 0.79) vs. (RMB 1.58) last year

Mar 25, 2025, 7:45 AM EDT - 1 year ago

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

2025-02-14T14:55:33.000Z - 1 year ago

Burning Rock Biotech Ltd (ADR) trading resumes

2025-02-14T14:51:11.000Z - 1 year ago

Burning Rock Biotech Ltd (ADR) trading halted, volatility trading pause

Dec 31, 2024, 4:56 AM EST - 1 year ago

Burning Rock Announces Results of 2024 Annual General Meeting

Dec 3, 2024, 11:59 PM EST - 1 year ago

Burning Rock Reports Third Quarter 2024 Financial Results

Dec 3, 2024, 6:45 AM EST - 1 year ago

Burning Rock Announces 2024 Annual General Meeting to be Held on December 31, 2024

2024-10-11T09:31:08.000Z - 1 year ago

Burning Rock Biotech, Dizal announce NMPA approval for sunvozertinib CDx

Oct 10, 2024, 11:16 PM EDT - 1 year ago

NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China

2024-09-27T12:40:22.000Z - 1 year ago

Burning Rock Biotech CFO Leo Li resigns

Sep 27, 2024, 8:37 AM EDT - 1 year ago

Burning Rock Announces Changes to Management and Board of Directors

Aug 22, 2024, 11:59 PM EDT - 1 year ago

Burning Rock Reports Second Quarter 2024 Financial Results

Aug 19, 2024, 2:21 AM EDT - 1 year ago

Burning Rock Biotech Limited Announces Expected Delisting of American Depositary Shares

Jun 3, 2024, 12:41 AM EDT - 2 years ago

Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement

2024-05-30T09:09:57.000Z - 2 years ago

Burning Rock Biotech enters collaboration with Bayer to develop cancer medicine

May 30, 2024, 3:42 AM EDT - 2 years ago

Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines

May 29, 2024, 8:00 AM EDT - 2 years ago

Burning Rock Biotech Earnings Call Transcript: Q1 2024

May 29, 2024, 1:34 AM EDT - 2 years ago

Burning Rock Reports First Quarter 2024 Financial Results

May 23, 2024, 2:00 AM EDT - 2 years ago

Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024

2024-05-14T23:50:00.000Z - 2 years ago

Burning Rock Biotech Ltd (ADR) trading halted, news pending

May 14, 2024, 2:02 AM EDT - 2 years ago

Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024

Apr 29, 2024, 3:30 AM EDT - 2 years ago

Burning Rock Publishes 2023 Annual Report on Form 20-F

2024-04-26T09:27:59.000Z - 2 years ago

Burning Rock Biotech announces one-for-ten ratio change

Apr 26, 2024, 1:59 AM EDT - 2 years ago

Burning Rock Announces ADS Ratio Change

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Burning Rock Biotech Earnings Call Transcript: Q4 2023

Mar 28, 2024, 5:16 PM EDT - 2 years ago

Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results

2024-01-04T10:23:29.000Z - 2 years ago

Burning Rock Biotech receives noncompliance notification from Nasdaq

Jan 4, 2024, 1:03 AM EST - 2 years ago

Burning Rock Announces Receipt of Notification from NASDAQ

Dec 19, 2023, 9:35 PM EST - 2 years ago

Burning Rock Announces Results of 2023 Annual General Meeting

Nov 30, 2023, 7:00 AM EST - 2 years ago

Burning Rock Biotech Earnings Call Transcript: Q3 2023

Nov 30, 2023, 1:25 AM EST - 2 years ago

Burning Rock Reports Third Quarter 2023 Financial Results

Nov 22, 2023, 2:04 AM EST - 2 years ago

Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023

Nov 20, 2023, 8:55 PM EST - 2 years ago

Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023

Oct 30, 2023, 3:20 AM EDT - 2 years ago

Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics

Oct 15, 2023, 7:18 PM EDT - 2 years ago

Burning Rock Received Breakthrough Device Designation from China's NMPA for its Multi-Cancer Early Detection Test

Sep 7, 2023, 10:43 PM EDT - 2 years ago

Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell

Aug 31, 2023, 8:00 AM EDT - 2 years ago

Burning Rock Biotech Earnings Call Transcript: Q2 2023

Aug 31, 2023, 1:30 AM EDT - 2 years ago

Burning Rock Reports Second Quarter 2023 Financial Results

Aug 4, 2023, 3:27 AM EDT - 3 years ago

Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023

Jun 28, 2023, 4:05 AM EDT - 3 years ago

Burning Rock Announces Resignation and Appointment of Directors

Jun 8, 2023, 12:20 AM EDT - 3 years ago

Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine

May 30, 2023, 8:00 AM EDT - 3 years ago

Burning Rock Biotech Earnings Call Transcript: Q1 2023

May 30, 2023, 12:53 AM EDT - 3 years ago

Burning Rock Reports First Quarter 2023 Financial Results

Apr 27, 2023, 1:01 AM EDT - 3 years ago

Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023

Apr 20, 2023, 10:43 PM EDT - 3 years ago

Burning Rock Publishes 2022 Annual Report on Form 20-F

Mar 28, 2023, 8:00 AM EDT - 3 years ago

Burning Rock Biotech Earnings Call Transcript: Q4 2022

Mar 28, 2023, 2:08 AM EDT - 3 years ago

Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 7, 2023, 3:38 AM EST - 3 years ago

Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023

2023-01-18T10:50:47.000Z - 3 years ago

Burning Rock Biotech raises FY22 revenue growth view to 10% from 5%

Jan 17, 2023, 8:37 PM EST - 3 years ago

Burning Rock provides an update on 2022 revenue guidance

2023-01-03T14:27:11.000Z - 3 years ago

Burning Rock Biotech’s cancer detection test designated Breakthrough Device

Jan 3, 2023, 9:25 AM EST - 3 years ago

Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

Nov 16, 2022, 8:30 AM EST - 3 years ago

Burning Rock Biotech Earnings Call Transcript: Q3 2022

Nov 15, 2022, 9:20 PM EST - 3 years ago

Burning Rock Reports Third Quarter 2022 Financial Results

Nov 1, 2022, 6:10 AM EDT - 3 years ago

Admission to Trading on the London Stock Exchange

Oct 27, 2022, 7:50 AM EDT - 3 years ago

Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange

Oct 25, 2022, 12:46 AM EDT - 3 years ago

Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022

Oct 21, 2022, 1:01 PM EDT - 3 years ago

Burning Rock Announces Publication of Registration Document and Potential Direct Listing on the London Stock Exchange

Sep 8, 2022, 4:56 AM EDT - 3 years ago

Burning Rock Announces Results of 2022 Annual General Meeting

Aug 31, 2022, 8:30 AM EDT - 4 years ago

Burning Rock Biotech Earnings Call Transcript: Q2 2022

Aug 31, 2022, 5:29 AM EDT - 4 years ago

Burning Rock Reports Second Quarter 2022 Financial Results

MarketBeat May. 13 at 2:08 PM

https://marketbeat.com/a/8652614/ $BNR Brenntag Q1 Earnings Call Highlights

0 · Reply

OfficialStocktwitsUser May. 2 at 1:09 AM

0 · Reply

BleedingStockPicker Mar. 16 at 2:00 PM

$BNR when I try to add in Charles Schwab states this order is not allowed for electronic entry. I have to call them. WTF?

1 · Reply

funnymoney90210 Mar. 6 at 3:05 AM

$BNR all chinese stocks getting delisted soon

0 · Reply

OfficialStocktwitsUser Feb. 27 at 9:37 PM

0 · Reply

BillionerOfKing Feb. 22 at 1:50 PM

$BNR Current Stock Price: $29.00

0 · Reply

DeltaWalker Feb. 18 at 10:23 AM

$BNR China clean energy exposure with policy dependency.

0 · Reply

RHoney Feb. 4 at 1:43 PM

$BNR escalating levels of support.

1 · Reply

BillionerOfKing Jan. 28 at 3:13 PM

$BNR Current Stock Price: $35.97

0 · Reply

RHoney Jan. 25 at 12:46 PM

$BNR lots of upside potential , this uptick has a long way to go

0 · Reply

isaacwilliams33 Jan. 13 at 6:44 PM

$BNR was doing good last yime I checked

0 · Reply

DeepLearningD3 Dec. 26 at 4:10 PM

$BNR Expectations are recalibrating toward pragmatic delivery instead of lofty projections. Cash efficiency must trend upward while maintaining strategic flexibility. Clear execution would attract broader institutional participation. Durable value creation requires execution to catch up with vision.

1 · Reply

FinTechFighter Dec. 24 at 12:37 PM

$BNR Sentiment could pivot sharply depending on how measurable traction replaces episodic catalyst-driven interest. Execution slippage remains the dominant downside risk.

0 · Reply